Endra Life Sciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Endra Life Sciences Inc
TickerNDRA
CIK #0001681682
CUSIP29273B500
SectorLife Sciences - Electromedical & Electrotherapeutic Apparatus
Address3600 Green Court Suite 350, Ann Arbor, MI 48105
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Endra Life Sciences Inc 2025-10-24 14.4 M Exemption: 506(c) · Minimum: $200,000 · Duration: One year or less · Commission: $295,498 · Revenue: No Revenues
CIK Filing 2011 - 2026
[0001681682] 10-K
[0001681682] 10-Q
[0001681682] 3
[0001681682] 4
[0001681682] 8-K
[0001681682] D
[0001681682] SC 13D
[0001681682] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Digiandomenico Anthony Endra Life Sciences Inc [2025-11-26] 0.0
Lipman John C Endra Life Sciences Inc [2025-10-30] 0.0
ATW Partners Opportunities Management LLC Endra Life Sciences Inc [2025-10-28] 0.0
SHN Financial Investments Ltd Endra Life Sciences Inc [2024-06-14] 0.99
L1 Capital Global Opportunities Master Fund Ltd Endra Life Sciences Inc [2024-06-14] 0.99
Bryan Michael SR Endra Life Sciences Inc [2023-03-10] 6.1
Longboard Capital Advisors LLC Endra Life Sciences Inc [2019-02-14] 4.36
ICM Asset Management Inc/Wa Endra Life Sciences Inc [2018-11-07] 10.4
Longboard Capital Advisors LLC Endra Life Sciences Inc [2017-07-13] 16.7
Form 3/4/5 Filer 2011 - 2026
Jacroux Richard
ENDRA Life Sciences Inc
Tokman Alexander Y
Digiandomenico Anthony
Basenese Lou
Harsh Michael
UBS Group AG
Thornton Michael Milos
Pestrikova Irina
Michelon Francois Roger
Maloberti Renaud Bertrand
Wells David R
Gambhir Sanjiv Sam
Conrad Brett
Longboard Capital Advisors LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Tokman Alexander Y
Common Stock
2026-03-02 Grant 26,921 $0.00
Jacroux Richard
Common Stock
2026-03-02 Grant 13,461 $0.00
Tokman Alexander Y
Common Stock
2026-01-21 Grant 75,000 $0.00
Digiandomenico Anthony
Common Stock
2026-01-21 Grant 60,324 $0.00
Basenese Lou
Common Stock
2026-01-21 Grant 60,324 $0.00
Jacroux Richard
Common Stock
2026-01-21 Grant 20,000 $0.00
Harsh Michael
Common Stock
2026-01-21 Grant 60,324 $0.00
Digiandomenico Anthony
Warrants · derivative
2025-10-10 Grant 141,644 $7.06 1,000,007
Digiandomenico Anthony
Common Stock
2025-10-10 Grant 70,822 $7.06 500,003
Basenese Lou
Common Stock
2025-06-11 Grant 5,384 $0.00
Harsh Michael
Common Stock
2025-06-11 Grant 5,384 $0.00
Digiandomenico Anthony
Common Stock
2025-06-11 Grant 5,384 $0.00
Common Stock
2024-08-27 Buy 0 $0.00
UBS Group AG
Common Stock
2024-08-27 Buy 3,715 $0.55 2,043
Digiandomenico Anthony
Stock Options · derivative
2024-01-02 Grant 600 $0.00
Tokman Alexander Y
Stock Options · derivative
2024-01-02 Grant 600 $0.00
Harsh Michael
Stock Options · derivative
2024-01-02 Grant 600 $0.00
Basenese Lou
Stock Options · derivative
2024-01-02 Grant 600 $0.00
Thornton Michael Milos
Common Stock
2023-05-18 Buy 15,000 $1.65 24,750
Digiandomenico Anthony
Common Stock
2023-05-02 Buy 83,333 $1.20 100,000
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 8 89,636
2025-12-31 7 71,825
2025-09-30 5 13,086
2025-06-30 4 4,736
2025-03-31 3 1,134
2024-12-31 5 115
2024-06-30 18 830,075
2024-03-31 14 264,625
2023-12-31 12 134,713
2023-09-30 11 140,717
2023-06-30 13 190,495
2023-03-31 15 168,273
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com